Cancer screening saves lives. The American Cancer Society (ACS) estimates that regular screening and early detection could prevent thousands of cancer deaths each year. Yet many adults are unsure about which screenings they need, when to start, and how often to be tested. This comprehensive guide consolidates all current ACS cancer screening guidelines to help you understand exactly what you need and when.
Key Takeaways
- The American Cancer Society recommends regular screening for breast, cervical, colorectal, and lung cancers based on age and risk factors.
- Breast cancer screening should begin at age 40 with annual mammograms recommended starting at age 45, transitioning to biennial at age 55.
- Colorectal cancer screening now starts at age 45 for average-risk adults, with multiple test options including colonoscopy, FIT, and stool DNA testing.
- Lung cancer screening with low-dose CT is recommended for adults aged 50-80 with a significant smoking history of 20+ pack-years.
- Shared decision-making between patients and providers is essential for prostate cancer screening and lung cancer screening eligibility.
How We Validated This Guide
| Validation Step | Method | Source |
|---|---|---|
| Screening recommendations | Official ACS guidelines review | American Cancer Society |
| Complementary guidelines | USPSTF recommendations cross-reference | US Preventive Services Task Force |
| Statistical data | Cancer Facts and Figures report | American Cancer Society |
| Screening efficacy | Systematic review of clinical trials | National Cancer Institute |
| Age and frequency protocols | Evidence-based consensus review | Multiple peer-reviewed sources |
Why Cancer Screening Matters
Cancer remains the second leading cause of death in the United States. The ACS projects that in 2026, approximately 2 million new cancer cases will be diagnosed. However, when detected early through screening, many cancers have significantly higher survival rates:
| Cancer Type | 5-Year Survival (Localized) | 5-Year Survival (Distant/Metastatic) |
|---|---|---|
| Breast Cancer | 99% | 31% |
| Colorectal Cancer | 91% | 15% |
| Cervical Cancer | 92% | 19% |
| Lung Cancer | 63% | 8% |
| Prostate Cancer | >99% | 34% |
These numbers illustrate a clear pattern: early detection through screening dramatically improves outcomes. The gap between localized and distant-stage survival rates underscores why following ACS screening guidelines is one of the most impactful health decisions you can make.
ACS Cancer Screening Guidelines by Cancer Type
Breast Cancer Screening
The ACS recommends the following breast cancer screening schedule for women at average risk:
Ages 40-44: Women should have the option to begin annual mammogram screening. This is considered an individual choice based on personal values and risk assessment.
Ages 45-54: Annual mammograms are strongly recommended. During this age range, breast cancer is more common and tumors tend to grow faster, making annual screening optimal.
Age 55 and older: Women may transition to biennial (every 2 years) mammograms or continue annual screening. This decision should be based on shared decision-making with a healthcare provider, considering overall health and life expectancy.
Screening should continue as long as a woman is in good health and expected to live at least 10 more years.
For women at higher risk (family history, BRCA mutations, chest radiation therapy before age 30, or genetic syndromes), the ACS recommends starting screening earlier, typically at age 30, with breast MRI in addition to mammography.
Cervical Cancer Screening
Cervical cancer screening guidelines depend on age and the type of test used:
Ages 25-65: Primary HPV testing every 5 years is the preferred approach. If primary HPV testing is not available, co-testing (HPV test plus Pap smear) every 5 years or a Pap smear alone every 3 years are acceptable alternatives.
Age 65 and older: Women who have had adequate negative prior screening (three consecutive negative Pap tests or two consecutive negative HPV tests within the past 10 years, with the most recent test within 5 years) can stop screening.
After hysterectomy: Women who have had a total hysterectomy (removal of the cervix) for non-cancerous reasons and have no history of cervical precancer do not need screening.
The shift toward HPV-based testing reflects the understanding that persistent HPV infection causes nearly all cervical cancers. The HPV test is more sensitive than the Pap smear alone, allowing for longer screening intervals while maintaining safety.
Colorectal Cancer Screening
In 2018, the ACS updated its colorectal cancer screening recommendation to begin at age 45 for adults at average risk, lowering the previous starting age of 50. This change was driven by rising colorectal cancer rates among younger adults.
Starting age: 45 for adults at average risk
Screening options (any of the following are acceptable):
| Test Type | Frequency | Notes |
|---|---|---|
| Colonoscopy | Every 10 years | Gold standard; detects and removes polyps |
| CT Colonography (Virtual Colonoscopy) | Every 5 years | Less invasive; requires bowel prep |
| Flexible Sigmoidoscopy | Every 5 years | Examines only the lower colon |
| Fecal Immunochemical Test (FIT) | Annually | At-home stool test; no bowel prep |
| Multi-target Stool DNA Test (Cologuard) | Every 3 years | At-home test; detects DNA mutations |
| FIT-DNA Combination | Every 3 years | Combines FIT with DNA markers |
Stopping age: The ACS recommends continuing screening until age 75. For adults aged 76-85, screening should be based on shared decision-making, considering overall health, prior screening history, and patient preferences.
Lung Cancer Screening
Lung cancer screening with low-dose computed tomography (LDCT) is recommended for individuals who meet all of the following criteria:
- Age: 50 to 80 years old
- Smoking history: 20 pack-years or more (one pack per day for 20 years, or two packs per day for 10 years)
- Current smoking status: Currently smoke or have quit within the past 15 years
Screening frequency: Annual low-dose CT scan
Shared decision-making: Before starting screening, the ACS recommends a discussion with a healthcare provider about the benefits, limitations, and potential harms of screening, including the possibility of false-positive results leading to unnecessary follow-up procedures.
The National Lung Screening Trial demonstrated that LDCT screening reduced lung cancer mortality by 20% compared to chest X-ray in high-risk individuals.
Prostate Cancer Screening
Prostate cancer screening involves shared decision-making between men and their healthcare providers:
Age 50 and older: Men at average risk should discuss prostate-specific antigen (PSA) testing with their healthcare provider.
Age 45 and older: Men at higher risk (African American men and men with a first-degree relative diagnosed with prostate cancer before age 65) should begin discussions earlier.
Age 40 and older: Men at highest risk (multiple family members diagnosed with prostate cancer at a young age) should begin discussions at this age.
The ACS recommends that men receive information about the benefits, risks, and uncertainties of prostate cancer screening before making a decision. PSA testing can detect prostate cancer early, but it can also lead to overdiagnosis and overtreatment of slow-growing cancers that may never cause symptoms.
Endometrial Cancer Screening
The ACS does not recommend routine endometrial cancer screening for women at average risk. Instead, the recommendation is:
- Women should be informed about the risks and symptoms of endometrial cancer at menopause.
- Any unexpected vaginal bleeding or spotting should be reported to a healthcare provider promptly.
- Women at high risk (Lynch syndrome, strong family history) should consider annual endometrial biopsy starting at age 35.
Skin Cancer Screening
The ACS recommends regular skin self-examination and awareness of skin changes. While there is no formal recommendation for routine skin cancer screening by a healthcare provider for average-risk individuals, the ACS advises:
- Be aware of all moles and spots on your skin
- Report any changes in size, shape, or color to a healthcare provider
- Use the ABCDE rule (Asymmetry, Border, Color, Diameter, Evolving) to evaluate suspicious spots
- People at high risk (fair skin, excessive sun exposure, family history, many moles) should consider professional skin examinations
ACS Screening Guidelines Summary by Age
| Age Range | Recommended Screenings |
|---|---|
| 25-39 | Cervical cancer screening (starting at 25 with primary HPV testing) |
| 40-44 | Breast cancer screening (optional, discuss with provider); Cervical cancer screening; Colorectal cancer screening discussion (if higher risk) |
| 45-49 | Breast cancer screening (annual starting at 45); Cervical cancer screening; Colorectal cancer screening (starting at 45); Prostate cancer screening discussion (if higher risk) |
| 50-54 | Breast cancer (annual); Cervical cancer; Colorectal cancer; Lung cancer (if qualifying smoking history); Prostate cancer (shared decision-making) |
| 55-64 | Breast cancer (annual or biennial); Cervical cancer; Colorectal cancer; Lung cancer (if eligible); Prostate cancer |
| 65-74 | Breast cancer; Colorectal cancer; Lung cancer (if eligible); Cervical cancer (may stop with adequate prior screening) |
| 75-85 | Colorectal cancer (shared decision-making); Breast cancer (if in good health with 10+ year life expectancy) |
Understanding Your Risk Level
ACS screening recommendations differ based on whether you are at average risk or higher risk for a particular cancer. Understanding your risk level is essential for appropriate screening.
Average Risk
You are considered at average risk if you have no personal history of cancer, no significant family history, no known genetic mutations, and no other major risk factors specific to the cancer type.
Increased Risk
You may be at increased risk based on:
- Family history: Having one or more first-degree relatives (parent, sibling, child) diagnosed with cancer, especially at a young age
- Genetic mutations: Known BRCA1, BRCA2, Lynch syndrome, or other hereditary cancer syndrome
- Personal history: Previous cancer diagnosis, precancerous conditions, or high-risk lesions
- Lifestyle factors: Smoking, excessive alcohol use, obesity, physical inactivity
- Environmental exposures: Radiation exposure, certain occupational chemicals
- Medical conditions: Chronic inflammatory conditions, immunosuppression
If you identify with any of these risk factors, discuss enhanced screening protocols with your healthcare provider.
Barriers to Cancer Screening and How to Overcome Them
Despite clear evidence that screening saves lives, many adults do not follow recommended screening schedules. Common barriers include:
Cost concerns: Under the Affordable Care Act, most insurance plans cover recommended cancer screenings at no cost to the patient. Medicare also covers screening mammograms, colonoscopies, and PSA testing.
Fear or anxiety: It is natural to feel anxious about screening, but the potential to detect cancer early when it is most treatable far outweighs the temporary discomfort of testing.
Lack of symptoms: Many people skip screening because they feel fine. However, early-stage cancers often produce no symptoms, which is exactly why screening is recommended before symptoms appear.
Logistical challenges: Newer screening options like at-home FIT tests and stool DNA tests have made colorectal cancer screening more accessible for people who cannot easily access colonoscopy facilities.
Conflicting information: With multiple organizations issuing screening guidelines, it can be confusing. The ACS guidelines represent an authoritative, evidence-based standard that your healthcare provider can use as a framework for your personalized plan.
Frequently Asked Questions
What is the difference between ACS and USPSTF screening guidelines?
The American Cancer Society and the US Preventive Services Task Force both issue evidence-based cancer screening guidelines. They sometimes differ in specific recommendations. The ACS guidelines tend to be more proactive (for example, recommending earlier screening start ages), while the USPSTF may take a more conservative approach. Your healthcare provider will consider both sets of guidelines along with your individual risk factors.
Are cancer screening tests covered by insurance?
Under the Affordable Care Act, private insurance plans are required to cover recommended preventive screening tests without cost-sharing (no copays or deductibles). Medicare covers mammograms, colonoscopies, Pap tests, and lung cancer screening for eligible beneficiaries. Check with your specific plan for details.
Can I choose a less invasive screening test?
In many cases, yes. For colorectal cancer screening, the ACS considers stool-based tests (FIT, stool DNA) to be acceptable alternatives to colonoscopy. However, if a stool-based test is abnormal, a follow-up colonoscopy is required. Discuss the trade-offs of each option with your provider.
How do I know if I need genetic testing for cancer risk?
Genetic testing may be recommended if you have a strong family history of cancer (multiple relatives with the same or related cancers, cancer diagnosed at young ages, or known genetic mutations in the family). Genetic counseling is the first step to determine whether testing is appropriate.
What should I do if a screening test is abnormal?
An abnormal screening result does not necessarily mean you have cancer. Many abnormal results are due to benign conditions. Your healthcare provider will recommend appropriate follow-up, which may include additional imaging, biopsy, or other diagnostic procedures. The important thing is to follow through with recommended follow-up promptly.
Is there a screening test for ovarian cancer?
Currently, there is no recommended population-wide screening test for ovarian cancer for women at average risk. The ACS recommends that women be aware of symptoms (bloating, pelvic or abdominal pain, difficulty eating, urinary urgency) and report them promptly. Women at high risk (BRCA mutations, Lynch syndrome, strong family history) should discuss surveillance options with their provider.
The Bottom Line
Following ACS cancer screening guidelines is one of the most important actions you can take for your health. Screening detects cancers at earlier, more treatable stages, and in some cases, can detect precancerous changes before cancer develops entirely. The key is knowing which screenings you need based on your age, sex, and risk factors, and following through consistently.
Do not wait for symptoms to appear. Talk to your healthcare provider about which cancer screenings are right for you, and use the ACS guidelines as a roadmap for staying on track. Early detection is your strongest defense against cancer.
WellAlly helps you track your screening schedule, organize your health records, and never miss an important test. Sign up for free to start managing your preventive health today.